2021 Hevolution, a global non-profit, launched to pro- vide early-stage investments that extend healthy years of life for everyone .
2021 Hevolution, a global non-profit, launched to pro- vide early-stage investments that extend healthy years of life for everyone .
August 2022 Hevolution’s $8.5M grant kick-started the New Investi- gator Awards to support early-career researchers with the American Federation for Aging Research (AFAR). the New Investi- gator Awards to
August 2022 Hevolution’s $8.5M grant kick-started support early-career researchers with the American Federation for Aging Research (AFAR).
May 2023 Hevolution’s $115M grant for the Geroscience Research Oppor- tunities Program funded interna- tional pre-clinical projects in aging biology.
May 2023 Hevolution’s $115M grant for the Geroscience Research Oppor- tunities Program funded interna- tional pre-clinical projects in aging biology.
November 2023 Inaugural Global Healthspan Summit (GHS), united 2500 global leaders in Riyadh, unveiling ~$100M in grants/ partnerships to propel the aging biology field. partnerships to propel the aging biology field.
November 2023 Inaugural Global Healthspan Summit (GHS), united 2500 global leaders in Riyadh, unveiling ~$100M in grants/
December 2023 Hevolution makes first impact investment - Aeovian to advance selective MTORC1 inhibitors to address age-related diseases.
December 2023 Hevolution makes first impact investment - Aeovian to advance selective MTORC1 inhibitors to address age-related diseases.
Made with FlippingBook Annual report maker